We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $21.5B
1-Year Est. Return 81.81%
This Fund
S&P 500
This Quarter Est. Return
+24.89%
1 Year Est. Return
+81.81%
3 Year Est. Return
+226.72%
5 Year Est. Return
+294.21%
10 Year Est. Return
AUM
$21.5B
AUM Growth
+$4.34B
Cap. Flow
+$423M
Cap. Flow %
1.97%
Top 10 Hldgs %
19.17%
Holding
2,170
New
686
Increased
353
Reduced
351
Closed
575

Sector Composition

Rank Sector Weight
1 Miscellaneous 88.42%
2 Technology 5.01%
3 Healthcare 1.9%
4 Consumer Discretionary 1.75%
5 Financials 1.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GIL icon
1176
Gildan
GIL
$8.5B
$877K ﹤0.01%
+17,000
New +$976K
CLOV icon
1177
CALL
Clover Health Investments
CLOV
$2.48B
$876K ﹤0.01%
167,200
BWXT icon
1178
CALL
BWX Technologies
BWXT
$13.4B
$876K ﹤0.01%
4,500
-9,500
-68% -$1.98M
PURR
1179
Hyperliquid Strategies Inc
PURR
$2.22B
$866K ﹤0.01%
+110,000
New +$814K
HAYW icon
1180
CALL
Hayward Holdings
HAYW
$2.7B
$866K ﹤0.01%
+50,000
New +$730K
HAYW icon
1181
PUT
Hayward Holdings
HAYW
$2.7B
$866K ﹤0.01%
+50,000
New +$730K
ITRI icon
1182
CALL
Itron
ITRI
$4.04B
$865K ﹤0.01%
+10,000
New +$854K
OSPN icon
1183
CALL
OneSpan
OSPN
$657M
$861K ﹤0.01%
+60,000
New +$758K
TGB
1184
PUT
Trekor Metals
TGB
$2.92B
$860K ﹤0.01%
+125,000
New +$893K
INSG icon
1185
PUT
Inseego
INSG
$68M
$854K ﹤0.01%
82,700
-27,300
-25% -$366K
EE icon
1186
Excelerate Energy
EE
$1.13B
$836K ﹤0.01%
22,000
-8,590
-28% -$296K
EOSE icon
1187
Eos Energy Enterprises
EOSE
$1.48B
$830K ﹤0.01%
141,184
-35,216
-20% -$245K
KN icon
1188
CALL
Knowles
KN
$2.97B
$830K ﹤0.01%
+20,000
New +$694K
BHC icon
1189
PUT
Bausch Health
BHC
$2.12B
$828K ﹤0.01%
+167,900
New +$901K
DHT icon
1190
PUT
DHT Holdings
DHT
$3.57B
$827K ﹤0.01%
+50,000
New +$893K
CCCC icon
1191
CALL
C4 Therapeutics
CCCC
$422M
$826K ﹤0.01%
+176,800
New +$605K
APYX icon
1192
Apyx Medical
APYX
$125M
$822K ﹤0.01%
183,003
-2,748
-1% -$10.9K
CRSP icon
1193
PUT
CRISPR Therapeutics
CRSP
$5.01B
$818K ﹤0.01%
15,000
+1,500
+11% +$79.1K
RNA
1194
CALL
Atrium Therapeutics
RNA
$173M
$818K ﹤0.01%
60,800
NICE icon
1195
PUT
Nice
NICE
$6.09B
$818K ﹤0.01%
+9,000
New +$873K
JBLU icon
1196
JetBlue
JBLU
$1.61B
$813K ﹤0.01%
+141,802
New +$722K
SONY icon
1197
Sony
SONY
$140B
$812K ﹤0.01%
+40,500
New +$854K
MX icon
1198
CALL
Magnachip Semiconductor
MX
$102M
$804K ﹤0.01%
+170,000
New +$824K
AMRZ
1199
CALL
Amrize Ltd
AMRZ
$21.5B
$800K ﹤0.01%
+15,000
New +$812K
CRON
1200
Cronos Group
CRON
$1.18B
$798K ﹤0.01%
286,947
-84,114
-23% -$226K

Similar funds

Caption Management's Q2 2026 Portfolio in Review

As of Q2 2026, Caption Management held 2,170 positions worth $21.5B, up 25% from $17.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Caption Management's Q2 2026 filing shows 686 new, 353 increased, 351 reduced and 575 closed positions. Its largest new stake was TSMC: 565,700 shares worth $270M. The largest sale was Meta Platforms (Facebook), an estimated $52.2M.

By sector, the portfolio is most concentrated in Miscellaneous at 88% of assets, down from 89% a quarter earlier, followed by Technology and Healthcare.

  • Caption Management's largest Q2 2026 buy was TSMC: 565,700 shares worth $270M.
  • Caption Management added most to Microsoft in Q2 2026, an estimated $198M increase.
  • Caption Management's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $52.2M.
  • Caption Management fully exited Planet Labs PBC Warrants in Q2 2026, selling an estimated $24.9M.
  • Caption Management's ten largest holdings make up 19% of its $21.5B portfolio in Q2 2026.
  • Caption Management opened 686 new positions and closed 575 in Q2 2026.
  • Caption Management's portfolio value rose 25% quarter-over-quarter to $21.5B.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.